Estimating LV Ejection Fraction by Bi-Plane Simpson Method on Echocardiography

Watch above video showing LVEF estimation by Simpson method.

The Simpson method calculates left ventricular ejection fraction (LVEF) by tracing the endocardial border of the left ventricle in both apical four-chamber and two-chamber views. The volumes during diastole and systole are determined, and LVEF is calculated as the difference between these volumes divided by the end-diastolic volume. Steps to Calculate LVEF Using Simpson's Method

Obtain Views:
- Acquire apical four-chamber and two-chamber views of the heart.
- Ensure optimal imaging quality to avoid foreshortening.
Trace Endocardial Borders:
- In both views, trace the endocardial border of the left ventricle during end-diastole (maximum volume) and end-systole (minimum volume).
- Be careful to exclude structures like papillary muscles from the tracing.
Calculate Volumes:
- Use the traced areas to calculate the left ventricular end-diastolic volume (LVEDV) and left ventricular end-systolic volume (LVESV).
- The volumes can be computed using the formula:
  - LVEDV = Volume at end-diastole
  - LVESV = Volume at end-systole
Apply the Ejection Fraction Formula:
- Calculate the ejection fraction using the formula:
  - EF (%) = (LVEDV - LVESV) / LVEDV x 100
Interpret Results:
- A normal ejection fraction typically ranges from 55% to 69%.
- Values below this range may indicate varying degrees of heart dysfunction.

Considerations and Limitations

Operator Dependency:
- The accuracy of the Simpson method is highly dependent on the operator's skill and the quality of the echocardiographic images.
Image Quality:
- Poor image quality can lead to inaccurate volume measurements, affecting the ejection fraction calculation.
Arrhythmias and Wall Motion Abnormalities:
- These conditions can complicate the assessment and may hinder accurate tracing of the endocardial borders.

By following these steps and considerations, the Simpson method can provide a reliable estimate of left ventricular ejection fraction in clinical practice.

Comments

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...

𝘼𝙣𝙩𝙞𝙘𝙤𝙖𝙜𝙪𝙡𝙖𝙩𝙞𝙤𝙣 𝘼𝙛𝙩𝙚𝙧 𝙎𝙩𝙧𝙤𝙠𝙚

𝘼𝙣𝙩𝙞𝙘𝙤𝙖𝙜𝙪𝙡𝙖𝙩𝙞𝙤𝙣 𝘼𝙛𝙩𝙚𝙧 𝙎𝙩𝙧𝙤𝙠𝙚 in Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts. The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

2025 ESC Guidelines on INR Targets in Mechanical Valves

2025 ESC Guidelines on INR Targets in Mechanical Valves INR Targets in Patients With Mechanical Heart Valves Updated, guideline-oriented review Mechanical heart valves are inherently thrombogenic and require lifelong anticoagulation. Vitamin K antagonists, particularly warfarin, remain the standard therapy. The international normalized ratio (INR) is used to guide anticoagulation intensity and must be individualized based on valve type, valve position, and patient-related thromboembolic risk factors. Subtherapeutic INR increases the risk of valve thrombosis and systemic embolism, whereas excessive anticoagulation increases bleeding risk. Why INR control is critical Mechanical valves promote thrombosis due to non-physiological blood flow, high shear stress, and continuous contact between blood and artificial surfaces. These prothrombotic mechanisms persist for life. Direct oral anticoagulants are contraindicated in mechanical valves; therefore, VKAs remain mandatory. The goal of I...

Dr. Usman's Cardiology Notes

Search This Blog